Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
- PMID: 26960710
- DOI: 10.1007/s10549-016-3703-5
Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
Abstract
Erratum to: Breast Cancer Res Treat (2012),134:549–560,DOI 10.1007/s10549-012-2080-y. In the original publication of the article, Fig. 5c was published incorrectly. The authors apologize for this error and the correct Fig. 5c is given below.
Erratum for
-
Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.Breast Cancer Res Treat. 2012 Jul;134(2):549-60. doi: 10.1007/s10549-012-2080-y. Epub 2012 May 15. Breast Cancer Res Treat. 2012. PMID: 22585231
Similar articles
-
Erratum to: Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue.Breast Cancer Res Treat. 2016 Apr;156(2):401-2. doi: 10.1007/s10549-016-3712-4. Breast Cancer Res Treat. 2016. PMID: 26956972
-
Erratum to: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.Breast Cancer Res Treat. 2016 Apr;156(2):407-8. doi: 10.1007/s10549-016-3754-7. Breast Cancer Res Treat. 2016. PMID: 27000201
-
Erratum to: Decreased tongue pressure is associated with sarcopenia and sarcopenic dysphagia in the elderly.Dysphagia. 2015 Feb;30(1):88. doi: 10.1007/s00455-014-9583-0. Dysphagia. 2015. PMID: 25380677
-
Erratum to: PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy.Breast Cancer Res Treat. 2016 Apr;156(2):405-6. doi: 10.1007/s10549-016-3752-9. Breast Cancer Res Treat. 2016. PMID: 26993130 Free PMC article.
-
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.J Clin Oncol. 2008 Feb 10;26(5):814-9. doi: 10.1200/JCO.2007.15.3510. J Clin Oncol. 2008. PMID: 18258991 Review.
Cited by
-
Autophagy: A challengeable paradox in cancer treatment.Cancer Med. 2023 May;12(10):11542-11569. doi: 10.1002/cam4.5577. Epub 2023 Feb 9. Cancer Med. 2023. PMID: 36760166 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources